As Texas' restrictive abortion bill reaches the Supreme Court, all eyes turn to Justice Anthony Kennedy, whose swing vote may settle the outcome.
Endo International agreed to stop marketing Opana ER as crush resistant. Under an agreement with the New York State, it also announced that it will stop downplaying the risks of addiction linked with the narcotic
Valeant Pharmaceuticals finally responded to the investor's queries. The company said that the Executive Vice President, Deb Jorn, had not been asked to leave, insisting that she had resigned because of personal reasons.